Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients

Annals of Hepatology

Volumn 12, Issue 4, 2013, Pages 413-419

  Janicko, Martin ^a   Veselíny, Eduard ^a   Leško, Dušan ^a   Jarcuška, Peter ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Cholesterol; Lipoproteins; Liver cirrhosis; Mortality; Prognosis

Indexed keywords

BILIRUBIN; CHOLESTEROL; CREATININE; TRIACYLGLYCEROL;

ACCURACY; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84885811527     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31342-0     Document Type: Article

References (16)

1. Krahenbuhl L, Lang C, Ludes S, Seiler C, Schafer M, Zimmermann A, Krahenbuhl S. Reduced hepatic glycogen stores in patients with liver cirrhosis. Liver Int 2003; 23: 101-9.
2. Vogt J. Gluconeogenesis in patients with impaired liver function. Zeitschrift fur Ernahrungswissenschaft 1997; 36: 364-7.
3. Wang TY, Newby LK, Chen AY. Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome. Clinical Cardiology 2009; 32: E22-E28.
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
5. Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Archives of internal medicine. 1997; 157: 792-6.
6. Llovet JM, Planas R, Morillas R, Quer JC, Cabre E, Boix J, Humbert P, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993; 88: 388-92.
7. Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach. Hepato-gastroenterology 1985; 32: 270-2.
8. D'Arienzo A, Manguso F, Scaglione G, Vicinanza G, Bennato R, Mazzacca G. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol 1998; 33: 1213-8.
9. Jiang M, Liu F, Xiong WJ. Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis. World J Gastroenterol 2010; 16: 1397-401.
10. Charlton-Menys V, Durrington PN. Human cholesterol metabolism and therapeutic molecules. Experimental physiology 2008; 93: 27-42.
11. Davidson M, Jacobson TA. How Statins Work: The Development of Cardiovascular Disease and Its Treatment With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors. Medscape. (Serial online) 2001 13.4.2011. (Cited 13.4.2011). Available from: http://www.medscape.org/viewprogram/608
12. Malmendier CL, Delcroix C, Lontie JF. Kinetics of a heterogeneous population of particles in low density lipoprotein apolipoprotein B. Atherosclerosis 1989; 80: 91-100.
13. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75.
14. Shah SS, Desai HG. Apolipoprotein deficiency and chronic liver disease. J Assoc Physicians India 2001; 49: 274-8.
15. Habib A, Mihas AA, Abou-Assi SG. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin Gastroenterol Hepatol 2005; 3: 286-91.
16. Fernández Pérez FJ, Pallarés Manrique H, Cabello Ramírez M. Zieve's syndrome. A case report. Rev Esp Enferm Dig 1996; 3: 226-9.